PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19087113-11	2008	In Unverricht-Lundborg PME, new cohorts with genotyped cystatin B mutations have led to the chronic use of antioxidant N-acetylcysteine and combination valproate clobazam or clonazepam plus antimyoclonic drugs topiramate, zonisamide, piracetam, levetiracetam, or brivaracetam.	Zonisamide	222-232	cystatin B	Homo sapiens	55-65	
20939070-3	2011	We carried out a pilot, open-label trial of add-on zonisamide (ZNS) in patients with EPM1.	Zonisamide	51-61	cystatin B	Homo sapiens	85-89	
20939070-3	2011	We carried out a pilot, open-label trial of add-on zonisamide (ZNS) in patients with EPM1.	Zonisamide	63-66	cystatin B	Homo sapiens	85-89	
20939070-9	2011	Our trial suggests that ZNS may be a valuable therapeutic option in EPM1 patients.	Zonisamide	24-27	cystatin B	Homo sapiens	68-72